Company Overview: Rock Creek

Industry News

1 Jun

Rock Creek Pharmaceuticals to Present at the 2016 BIO International Convention and the LD Micro Invitational Conference

SARASOTA, Fla., June 1, 2016 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, announced today that Michael Mullan, MBBS, Ph.D., Chairman and CEO of Rock Creek Pharmaceuticals, will be presenting the Company’s...

Read more

5 May

Rock Creek Pharmaceuticals Announces Japanese, European and U.S. Patent Developments and Valuation Initiative for Lead Compound

SARASOTA, Fla., May 5, 2016 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (RCPI), a clinical-stage drug development company focused on the application of its lead compound to treat acute and chronic inflammatory conditions, announced today recent additions to the Company’s intellectual property (IP) portfolio.  As exemplified below, the Company continues to protect...

Read more

1 Mar

Rock Creek Pharmaceuticals Announces the Addition of Distinguished Dermatologist as a Scientific Advisor

SARASOTA, Fla., March 1, 2016 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (OTCQB: RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat acute and chronic inflammatory conditions, announced today that the Company has retained one of the world’s leading experts in clinical dermatology and...

Read more

3 Feb

Rock Creek Pharmaceuticals Announces Inhibition of STAT 3 Activation, A Key Marker of Inflammation, In Phase I Clinical Trial in Europe

SARASOTA, Fla., Feb. 3, 2016 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (RCPI), a clinical stage drug development company which is focused on the application of its lead compound to treat acute and chronic inflammatory conditions, announced today that the Company has received an interim report of the pharmacodynamic (PD) results of...

Read more

5 Jan

Rock Creek Pharmaceuticals Presentation at Biotech Showcase 2016 to be Webcast

SARASOTA, Fla., Jan. 5, 2016 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (RCPI), a clinical stage drug development company which is focused on the application of its lead compound to treat chronic inflammatory conditions, announced today that the Company’s presentation at Biotech Showcase 2016 at the Parc 55, Hilton Hotel in San...

Read more

10 Dec

Rock Creek Pharmaceuticals to Present at Biotech Showcase 2016

SARASOTA, Fla., Dec. 10, 2015 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (RCPI), a clinical stage, drug development company which is focused on the application of its lead compound to treat chronic inflammatory conditions, announced today that the Company will present at Biotech Showcase 2016 on Monday, January 11, 2016 at 10:00AM...

Read more

3 Dec

Rock Creek Pharmaceuticals Announces the Addition of Key Opinion Leaders to Enhance Dermatological Disease Program

SARASOTA, Fla., Dec. 3, 2015 /PRNewswire/ — Rock Creek Pharmaceuticals, Inc., (RCPI), a clinical stage drug development company focused on the application of its lead compound being developed to treat chronic inflammatory conditions, announced today that the Company has retained two eminent “Key Opinion Leaders” (KOLs), each having renowned international expertise...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address